Jonas Malmstedt
Affiliated to Research
E-mail: jonas.malmstedt@ki.se
Visiting address: Södersjukhuset, Sjukhusbacken 19, 11883 Stockholm
Postal address: S1 Klinisk forskning och utbildning, Södersjukhuset, S1 KI SÖS Forskning Kirurgi Gillgren, 118 83 Stockholm
About me
- I am a vascular surgeon and have worked in Stockholm since 10 years. My PhD
thesis, titled "Diabetes and Peripheral Arterial Disease [1]" was presented
in 2012 at the Department of Molecular Medicine and Surgery at Karolinska
Institute. Since March 2014 I have a 50% post-doc scholarship in combination
with clinical work at the Vascular section, the Department of Surgery,
Södersjukhuset. I am a member if the SOSVASC [2] research group at the
Department of Clinical Science and Education, Södersjukhuset.
My clinical interest for diabetes and peripheral arterial disease coincides
with my main line of research. My aim is to work translational based on the
clinical problems associated with peripheral arterial disease (PAD) and
diabetes.
Medical doctor 1995, University of Linköping [3]
Specialist in General Surgery 2003
Specialist in Vascular Surgery 2005
PhD 2012, Karolinska Institute.
[1] https://openarchive.ki.se/xmlui/handle/10616/41218
[2] http://ki.se/kisos/sosvasc
[3] http://www.liu.se/utbildning/program/lakare?l=sv& - amp
- gclid=Cj0KEQjw1pWrBRDuv-rhstiX6KwBEiQA5V9ZoWNQaNseGNGwTqigHwuR79Y5CiaY6LWEanR2mWH3u6UaAl2u8P8HAQ
Research
- *Projects*
* What is the cause of the rapid progression of arteriosclerosis and intimal
hyperplasia in diabetic patients?
In patients with diabetes advanced glycation end products (AGE) are produced.
These compounds have several effects on the wall structure as well as the
fuction of the arterial vessels. In animal studies it has been well described
how the AGE products induces arteriosclerosis and stimulates intimal
hyperplasia thru specific receptors in the vessel wall. Intimal hyperplasia
is an exaggerated healing process in the arterial wall that incuses stenoses
and occlusions after vascular procedures such as by-pass and angioplasty.
We are trying to describe if the mechanisms shown in the animal models also
are present in humans. We have described the presence of AGE and RAGE in the
veins used in by-pass surgery of the lower extremities.
* Why is the neo-formation of muscle vessels impaired in diabetic patients?
In this project we study the factors that inhibit neo-formation of vessels
(angiostatic factors) in muscle. In diabetic patients the compensatory
mechanisms for impaired circulation (in PAD) is reduced and neo-formation
process is defected. The mechanism behind this is not fully understood. We
will compare muscle samples from patients with, and without diabetes (and
with, and without PAD ) at a molecular biologic level. The project is a
collaboration with Ass prof Thomas Gustafsson at the Research group of
Integrative Clinical Physiology [1] and Ass Prof Tara Haas at the York
University in Canada. [2]
*Other ongoing projects*
The role of the intimal wall of the artery in bloodclot formation
* Treatment results of PAD in a 20-year perspective
* Does better perioperative glucose control reduce complications?
* Post traumatic care in blast and gunshot extremity wounds. PhD project for
Andres Älgå [3] (I am co-supervisor in this thesis projekt). We have
randomized 70 patientes comparing vacuum assisted clusure with
conventional wound treatment. Additionally we have shown an association
between infection after traumatic injuries to the lower extremities och
risk for amputation and death independent of age, gender and traumascore.
Aside from our data - collecten on site - we collect data from the Red
Cross registry in Pakistan.
* Trombocyte inhibition in PAD. PhD project for Ove Thott [4] (I am
co-supervisor)
* Cellular mechaniwsm in intimal hyperplasia and diabetes. PhD project for
Robert Saxelin [5] (I am co-supervisor)
* We plan to investigate diagnoses in vascular surgery in patients subjected
to pelvic radiotherapy. The project is a collaboration with Åsa Hallqvist
Everhov [6], Peter Gillgren [7] and Karin Ekström Smedby [8].
* I am co-supervisor to Eva Torbjörnsson [9] in her PhD project. Eva
studies the risk of amputation and quality of life in patients who have
undergone amputation. The studies are populationbased cohorts from
Stockholm, Sweden.
* I am principle investigator for the Basil-2 [10] trial. A randomized
multi-centre trial from University of Birmingham. The objective is to find
out if a "vein by-pass first" or a "best endovascular first"
revascularisation strategy is best, in terms of either clinical or
cost-effectiviness, for severe limb ischemia due to infra-popliteal
disease.
* We study the results after treatment for primary trmbosis of the
subclavian vein. This is a project in collaboration with Carl-Magnus
Wahlgren [11] and Peter Gillgren [12] along with a medical student (Sara
Lindblom)
* Natural History of Peripheral Arterial Disease
Fredrik Sartipy [13] M.D., has a PhD project. In collaboration with Dr
Birgitta Sigvant, Karlstad's Central Hospital, and Professor Eric Wahlberg
at Linköping University. I am co-supervisor. Sartipy will study quality
of life, disease panorama and death in patients with PAD. Sigvant holds a
PhD in the subject and a large cohort of patients is in our database
already
*SEVEN SELECTED PUBLICATIONS*
[pubmed:27406106]
[pubmed:16779879]
[pubmed:18268064]
[pubmed:18829239]
[pubmed:18851920]
[pubmed:15933983]
[pubmed:20920426]
[1] http://ki.se/en/labmed/research-group-of-integrative-clinical-physiology
[2] http://www.yorku.ca/thaas/
[3] http://ki.se/en/people/andalg
[4] https://kiedit.ki.se/people/ovetho
[5] https://kiedit.ki.se/people/robesa
[6] http://ki.se/en/people/asahal
[7] http://ki.se/en/people/petgil
[8] http://ki.se/en/people/kariek
[9] http://ki.se/en/people/evato
[10] http://www.birmingham.ac.uk/research/activity/mds/trials/bctu/trials/portfolio-v/Basil-2/index.aspx
[11] http://ki.se/en/people/cawahl
[12] http://ki.se/en/people/petgil
[13] http://ki.se/en/people/fresar
Articles
- Article: THE LANCET. 2023;401(10390):1798-1809
- Article: DISABILITY AND REHABILITATION. 2022;44(10):2149-2157
- Article: WORLD JOURNAL OF EMERGENCY SURGERY. 2022;17(1):9
- Article: PLOS ONE. 2022;17(10):e0277094
- Article: JOURNAL OF VASCULAR SURGERY. 2021;73(1):258-266.e1
- Article: JOURNAL OF VASCULAR SURGERY. 2020;71(4):1305-1314.e5
- Article: THE LANCET GLOBAL HEALTH. 2020;8(3):e423-e429
- Article: THE LANCET. 2019;394(10197):471-477
- Article: JMIR RESEARCH PROTOCOLS. 2018;7(11):e12334
- Article: EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY. 2017;53(3):403-410
- Article: EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY. 2016;52(5):597-603
- Article: STROKE. 2016;47(8):2083-2089
- Article: EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY. 2016;51(4):579-586
- Article: CARDIOVASCULAR DIABETOLOGY. 2015;14:93
- Article: JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY. 2010;4(5):1063-1072
- Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2009;88(10):1167-1170
- Article: EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY. 2008;36(6):705-712
- Article: JOURNAL OF NUCLEAR MEDICINE. 2008;49(10):1601-1605
- Article: DIABETES CARE. 2008;31(5):887-892
- Article: HEART SURGERY FORUM. 2006;9(6):E818-E819
- Article: BRITISH JOURNAL OF SURGERY. 2006;93(11):1360-1367
- Article: EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY. 2005;30(1):52-56
- Article: SCANDINAVIAN JOURNAL OF CLINICAL AND LABORATORY INVESTIGATION. 1999;59(5):325-334
- Show more
All other publications
- Editorial comment: WORLD JOURNAL OF SURGERY. 2023;47(6):1475-1476
- Editorial comment: EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY. 2020;60(3):409
- Editorial comment: EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY. 2020;59(3):335-336
- Thesis / dissertation: 2012
- Letter: EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY. 2010;40(3):414-415
- Published conference paper: JOURNAL OF VASCULAR SURGERY. 2008;48(6):1382-1388
Employments
- Affiliated to Research, Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, 2024-2027
Degrees and Education
- Degree Of Doctor Of Philosophy, Department of Molecular Medicine and Surgery, Karolinska Institutet, 2012